WallStreetZenWallStreetZen

NASDAQ: BNGO
Bionano Genomics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

BNGO past revenue growth

How has BNGO's revenue growth performed historically?
Company
29.9%
Industry
7.99%
Market
17.61%
BNGO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BNGO's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BNGO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BNGO earnings and revenue history

Current Revenue
$36.1M
Current Earnings
-$232.5M
Current Profit Margin
-643.7%

BNGO Return on Equity

Current Company
-140.6%
Current Industry
11.1%
Current Market
188%
BNGO's Return on Equity (-140.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BNGO announces earnings.

BNGO Return on Assets

Current Company
-96.9%
Current Industry
7.2%
BNGO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BNGO Return on Capital Employed

Current Company
-198.74%
Current Industry
9.7%
BNGO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BNGO vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BNGO$36.12M-$213.34M-$232.49M+24.65%N/A
MLSS$9.83M-$6.90M-$6.93M+0.42%N/A
POCI$19.22M-$1.29M-$1.72M+29.71%N/A
RVP$43.60M-$1.24M-$7.24M+5.55%N/A
FEMY$1.07M-$13.17M-$14.25M+3.64%N/A
View Top Medical Stocks

BNGO earnings dates

Next earnings date
May 7, 2024

Bionano Genomics Earnings & Revenue FAQ

What were BNGO's earnings last quarter?

On Invalid Date, Bionano Genomics (NASDAQ: BNGO) reported Q4 2023 earnings per share (EPS) of -$0.96, up 26.15% year over year. Total Bionano Genomics earnings for the quarter were -$43.89 million. In the same quarter last year, Bionano Genomics's earnings per share (EPS) was -$1.30.

If you're new to stock investing, here's how to buy Bionano Genomics stock.

What was BNGO's earnings growth in the past year?

As of Q2 2024, Bionano Genomics's earnings has grown year over year. Bionano Genomics's earnings in the past year totalled -$232.49 million.

What is BNGO's earnings date?

Bionano Genomics's earnings date is Invalid Date. Add BNGO to your watchlist to be reminded of BNGO's next earnings announcement.

What was BNGO's revenue last quarter?

On Invalid Date, Bionano Genomics (NASDAQ: BNGO) reported Q4 2023 revenue of $10.72 million up 30.51% year over year. In the same quarter last year, Bionano Genomics's revenue was $8.22 million.

What was BNGO's revenue growth in the past year?

As of Q2 2024, Bionano Genomics's revenue has grown 29.9% year over year. This is 21.91 percentage points higher than the US Medical Instruments & Supplies industry revenue growth rate of 7.99%. Bionano Genomics's revenue in the past year totalled $36.12 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.